Gladstone Institutional Advisory LLC Dexcom Inc Transaction History

Gladstone Institutional Advisory LLC

  • $2 Billion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$114.22 - $140.1 $30,039 - $36,846
-263 Reduced 11.58%
2,009 $278,000
Q4 2023

Feb 09, 2024
SELL
$75.49 - $124.16 $304,224 - $500,364
-4,030 Reduced 63.95%
2,272 $281,000
Q3 2023

Nov 13, 2023
SELL
$86.06 - $137.93 $3.08 Million - $4.94 Million
-35,789 Reduced 85.03%
6,302 $587,000
Q2 2023

Aug 10, 2023
BUY
$112.47 - $130.98 $4.73 Million - $5.51 Million
42,091 New
42,091 $5.41 Million
Q4 2022

Feb 01, 2023
BUY
$84.98 - $122.67 $552,964 - $798,213
6,507 New
6,507 $736,000
Q1 2022

May 04, 2022
SELL
$94.08 - $130.2 $318,743 - $441,117
-3,388 Closed
0 $0
Q4 2021

Jan 27, 2023
BUY
$129.87 - $162.82 $65,584 - $82,224
505 Added 17.52%
3,388 $1.82 Million
Q4 2021

Feb 11, 2022
BUY
$129.87 - $162.82 $65,584 - $82,224
505 Added 17.52%
3,388 $1.82 Million
Q3 2021

Jan 27, 2023
BUY
$106.71 - $143.18 $307,644 - $412,787
2,883 New
2,883 $1.58 Million
Q3 2021

Nov 15, 2021
BUY
$106.71 - $143.18 $307,644 - $412,787
2,883 New
2,883 $1.58 Million
Q3 2020

Nov 16, 2020
SELL
$95.51 - $112.95 $99,234 - $117,355
-1,039 Closed
0 $0
Q2 2020

Aug 17, 2020
BUY
$62.68 - $105.34 $2,256 - $3,792
36 Added 3.59%
1,039 $421,000
Q1 2020

May 14, 2020
BUY
$47.79 - $75.63 $47,933 - $75,856
1,003 New
1,003 $270,000

Others Institutions Holding DXCM

# of Institutions
1,014
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Gladstone Institutional Advisory LLC Portfolio

Follow Gladstone Institutional Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email